These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4566268)

  • 21. Serum fibrin degradation products in the diagnosis of transplantation rejection.
    Bennett NM; Bennett D; Holland NH; Luke RG
    Transplantation; 1972 Sep; 14(3):311-6. PubMed ID: 4564930
    [No Abstract]   [Full Text] [Related]  

  • 22. The pathologist and the kidney transplant.
    Corson JM
    Pathol Annu; 1972; 7():251-92. PubMed ID: 4557934
    [No Abstract]   [Full Text] [Related]  

  • 23. Inputs for dose calculations from compartmental models.
    Scheibe PO; Yoshikawa BM
    J Nucl Med; 1974 Nov; 15(11):1025-7. PubMed ID: 4609272
    [No Abstract]   [Full Text] [Related]  

  • 24. Urinary excretion of fibrinogen-related materials, complement, and immunoglobulins in proliferative glomerulonephritis and after renal transplantation.
    Hoq MS; Anderton JL; Cunningham M; Cash JD
    Br Med J; 1974 Jun; 2(5918):535-8. PubMed ID: 4209872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal eicosanoids.
    Norris SH
    Semin Nephrol; 1990 Jan; 10(1):64-88. PubMed ID: 2104991
    [No Abstract]   [Full Text] [Related]  

  • 26. Radio-fibrinogen catabolism and fibrin products for the assessment of renal disease.
    Wardle EN
    Nephron; 1977; 18(4):193-200. PubMed ID: 323738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploration of intraglomerular phenomena by measurement of the level of fibrin degradation products in the renal vein blood.
    Conte J; Boneu B; Mignon-Conte ; Suc JM
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):915-26. PubMed ID: 4807811
    [No Abstract]   [Full Text] [Related]  

  • 28. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.1 Differential diagnosis of chronic graft dysfunction.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():4-8. PubMed ID: 12091617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Qualitative analysis of urinary fibrin/fibrinogen degradation products in renal transplant rejection (author's transl)].
    Akiyama T
    Nihon Hinyokika Gakkai Zasshi; 1978 Nov; 69(11):1391-403. PubMed ID: 368396
    [No Abstract]   [Full Text] [Related]  

  • 30. [Urinary and serum fibrin/fibrinogen degradation products in renal transplant rejection (author's transl)].
    Akiyama T; Kaneko S; Iguchi M; Minami K; Kadowaki T
    Nihon Hinyokika Gakkai Zasshi; 1977 Jun; 68(6):599-608. PubMed ID: 335137
    [No Abstract]   [Full Text] [Related]  

  • 31. [Fibrin degradation products and fibrinolytic activity in most frequent renal diseases in children].
    Kleniewski J; Oleszkiewicz J
    Pediatr Pol; 1972 Jan; 47(1):49-54. PubMed ID: 5059017
    [No Abstract]   [Full Text] [Related]  

  • 32. Measurement of urinary fibrinogen-related material: methodologic aspects.
    Donati MB; Molla A; Michielsen P; Vermylen J
    J Lab Clin Med; 1974 Jun; 83(6):921-36. PubMed ID: 4214494
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum and urinary fibrin-fibrinogen degradation products in renal disease.
    Cash JD; Clarkson AR
    Scand J Haematol Suppl; 1971; 13():331-6. PubMed ID: 4945834
    [No Abstract]   [Full Text] [Related]  

  • 34. Fibrin-fibrinogen degradation products in children with renal disease.
    Uttley WS; Maxwell H; Cash JD
    Arch Dis Child; 1974 Feb; 49(2):137-42. PubMed ID: 4817446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TNF receptors: signaling pathways and contribution to renal dysfunction.
    Al-Lamki RS; Mayadas TN
    Kidney Int; 2015 Feb; 87(2):281-96. PubMed ID: 25140911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization of intrarenal cross-linked fibrin in children with various renal diseases.
    Kamitsuji H; Kusumoto K; Taira K; Iida Y; Nakajima M; Fukui H
    Nephron; 1983; 35(2):94-9. PubMed ID: 6621761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired renal allograft function: a comparative study with angiography and histopathology.
    Hamway S; Novick A; Braun WE; Levin H; Banowsky L; Alfidi R; Magnusson M
    J Urol; 1979 Sep; 122(3):292-7. PubMed ID: 381688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrin in renal disease: functional considerations.
    Wardle EN
    Clin Nephrol; 1974; 2(3):85-92. PubMed ID: 4604477
    [No Abstract]   [Full Text] [Related]  

  • 39. Significance of fibrin split products in patients with renal failure.
    Haanen C; Nováková I; Wijdeveld P; van Liebergen F
    Scand J Haematol Suppl; 1971; 13():345-50. PubMed ID: 4945835
    [No Abstract]   [Full Text] [Related]  

  • 40. F.D.P.
    Lancet; 1972 Nov; 2(7784):957-8. PubMed ID: 4116829
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.